Prognostic Value of Lymphocyte-to-Monocyte Ratio (LMR) in Cancer Patients Undergoing Immune Checkpoint Inhibitors

BACKGROUND: There is accumulating evidence that the lymphocyte-to-monocyte ratio (LMR) is related to the outcomes of cancer patients treated with immune checkpoint inhibitors (ICIs). However, the results remain controversial. METHOD: Electronic databases were searched to retrieve the studies that ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Luying, Wu, Chunlan, Luo, Shuimei, Xie, Xianhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803580/
https://www.ncbi.nlm.nih.gov/pubmed/36590752
http://dx.doi.org/10.1155/2022/3610038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803580/
https://www.ncbi.nlm.nih.gov/pubmed/36590752
http://dx.doi.org/10.1155/2022/3610038

Ejemplares similares